Denali Therapeutics (NASDAQ:DNLI) Releases Earnings Results

Denali Therapeutics (NASDAQ:DNLI – Get Free Report) released its earnings results on Wednesday. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.03), Briefing.com reports. During the same quarter in the prior year, the firm posted ($0.72) earnings per share. Denali Therapeutics Price Performance Denali Therapeutics stock traded down […]

Leave a Reply

Your email address will not be published.

Previous post Rolls-Royce Holdings plc (LON:RR) Earns “Overweight” Rating from JPMorgan Chase & Co.
Next post Astera Labs (NASDAQ:ALAB) Updates Q4 2024 Earnings Guidance